The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Duloxetine Clonmel 30 mg gastro resistant capsules, hard

30 milligram(s) Gastro-resistant capsule

Clonmel Healthcare LtdPA0126/269/002

Main Information

Trade NameDuloxetine Clonmel 30 mg gastro resistant capsules, hard
Active SubstancesDuloxetine
Strength30 milligram(s)
Dosage FormGastro-resistant capsule
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/269/002

Group Information



Licence Issued25/09/2015
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0091-033-006
Interchangeable List DocumentPDF of Interchangeable List
« Back